Kensey Nash (KNSY) Receives FDA Clearance for its First Extracellular Matrix Product, Medeor
Tweet Send to a Friend
Kensey Nash Corporation (Nasdaq: KNSY) announced that it has received 510(k) clearance for its first extracellular matrix (ECM) product, Medeor(TM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


